创金合信全球医药生物股票发起(QDII)A(018155)资产负债表
| |
2026-06-30 |
2025-12-31 |
2025-06-30 |
2024-12-31 |
| 资产 |
| 银行存款 |
- |
- |
- |
- |
| 结算备付金 |
123,270.98 |
2,308,548.90 |
19,116.35 |
43,199.92 |
| 存出保证金 |
297,738.30 |
133,871.22 |
14,411.47 |
87,151.93 |
| 交易性金融资产 |
249,754,508.68 |
764,058,539.73 |
11,707,017.51 |
10,443,164.83 |
| 其中：股票投资 |
230,934,180.28 |
764,058,539.73 |
11,707,017.51 |
10,443,164.83 |
| 债券投资 |
- |
- |
- |
- |
| 资产支持证券投资 |
- |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
- |
| 应收证券清算款 |
6,997,055.85 |
12,521,139.43 |
1,220,867.72 |
- |
| 应收利息 |
- |
- |
- |
- |
| 应收股利 |
- |
- |
- |
271.72 |
| 应收申购款 |
24,760,153.02 |
23,606,157.66 |
118,794.30 |
227,656.24 |
| 其他资产 |
- |
- |
- |
- |
| 资产总计 |
316,970,867.40 |
968,631,130.12 |
14,392,620.06 |
12,774,490.75 |
| 负 债 |
| 短期借款 |
- |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
- |
| 应付证券清算款 |
13,528,123.30 |
3,390,212.77 |
231,283.38 |
67,468.75 |
| 应付赎回款 |
11,695,973.60 |
138,229,923.92 |
274,026.73 |
40,262.56 |
| 应付管理人报酬 |
228,518.52 |
976,155.32 |
13,742.13 |
15,933.00 |
| 应付托管费 |
38,086.42 |
162,692.56 |
2,290.37 |
2,655.50 |
| 应付销售服务费 |
62,834.41 |
360,983.86 |
2,921.05 |
2,564.50 |
| 应付交易费用 |
- |
- |
- |
- |
| 应交税费 |
- |
- |
- |
- |
| 应付利息 |
- |
- |
- |
- |
| 应付利润 |
- |
- |
- |
- |
| 其他负债 |
122,129.56 |
445,766.13 |
21,441.54 |
27,296.98 |
| 负债合计 |
25,675,665.81 |
143,565,734.56 |
545,705.20 |
156,181.29 |
| 所有者权益 |
| 实收基金 |
179,244,805.07 |
484,678,760.92 |
12,731,078.35 |
13,894,416.59 |
| 未分配利润 |
112,050,396.52 |
340,386,634.64 |
1,115,836.51 |
-1,276,107.13 |
| 所有者权益合计 |
291,295,201.59 |
825,065,395.56 |
13,846,914.86 |
12,618,309.46 |
| 负债及所有者权益总计 |
316,970,867.40 |
968,631,130.12 |
14,392,620.06 |
12,774,490.75 |
微信公众号
证券之星APP
基本资料
